A solution for quickly creating and using digital therapies for various health conditions
Cogito: A turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics
This study is working on making it easier and faster to create helpful digital treatments for issues like substance use and anxiety, so that more people can access effective care that fits their needs.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Square2 Systems, INC. NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project ID | NIH-10918866 on NIH RePORTER |
What this research studies
This research focuses on developing a streamlined approach to create, evaluate, and deploy digital therapeutics, which are software-based treatments for medical conditions. By addressing the challenges of slow development and scalability, the project aims to enhance the effectiveness of digital therapies, particularly for conditions like substance use disorders and anxiety. Patients may benefit from improved access to effective treatments that are tailored to diverse populations and health needs. The methodology involves leveraging existing research to create clinical-grade software that can be rapidly adapted and implemented in various healthcare settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions such as ADHD, anxiety, or substance use disorders who may benefit from digital therapeutic interventions.
Not a fit: Patients with conditions that do not align with the focus of digital therapeutics, or those who prefer traditional in-person treatment methods, may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more effective and accessible digital treatment options for managing their health conditions.
How similar studies have performed: Previous research has shown that digital therapeutics can significantly improve treatment outcomes, indicating a promising potential for this approach.
Where this research is happening
Hanover, United States
- Square2 Systems, INC. — Hanover, United States (Active)
Researchers
- Principal investigator: Grabinski, Michael John — Square2 Systems, INC.
- Study coordinator: Grabinski, Michael John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.